Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Role of early viral infections in development of multiple sclerosis.
Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
CXCL13 antibody for the treatment of autoimmune disorders.
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.
RANDOM FOREST FLAIR RECONSTRUCTION FROM T 1, T 2, AND PD -WEIGHTED MRI.
Neuroendocrine Responses to Transvascular Autonomic Modulation: A Modified Balloon Angioplasty in Multiple Sclerosis Patients.
New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.
Does Disease-Irrelevant Intrathecal Synthesis in Multiple Sclerosis Make Sense in the Light of Tertiary Lymphoid Organs?
Multiple sclerosis registries in Europe - results of a systematic survey.
Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients.
Personalized medicine in multiple sclerosis: hope or reality?
MicroRNA regulation of lymphocyte tolerance and autoimmunity.

Pages